Sai Life Sciences Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

Sai Life Sciences' board meeting concluded with key updates for investors! The company reported consolidated revenue of ₹496.42 Cr and a net profit of ₹60.46 Cr for the quarter ended June 30, 2025. In leadership news, Mr. Krishnamraju Kanumuri was reappointed as MD & CEO for another five-year term, effective September 1, 2025, awaiting shareholder nod. Mark your calendars: the 26th Annual General Meeting is set for September 11, 2025, via video conference.